Evidence map›Paper›PMID 32045434›Full record

ArticlePloS one2020

Insights into the hyperglycosylation of human chorionic gonadotropin revealed by glycomics analysis.

Linda Ibeto, Aristotelis Antonopoulos, Paola Grassi, Poh-Choo Pang, Maria Panico, Shabnam Bobdiwala, Maya Al-Memar, Paul Davis, Mark Davis, Julian Norman Taylor and 8 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. The Immunology of Syncytialized Trophoblast.International journal of molecular sciences · 2021
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Linda IbetoDepartment of Life Sciences, Imperial College London, London, United Kingdom.ORCID 0000-0002-3570-6674
Aristotelis AntonopoulosDepartment of Life Sciences, Imperial College London, London, United Kingdom.
Paola GrassiDepartment of Life Sciences, Imperial College London, London, United Kingdom.
Poh-Choo PangDepartment of Life Sciences, Imperial College London, London, United Kingdom.
Maria PanicoDepartment of Life Sciences, Imperial College London, London, United Kingdom.
Shabnam BobdiwalaTommys' National Centre for Miscarriage Research, Queen Charlottes' & Chelsea Hospital, Imperial College, London, United Kingdom.
Maya Al-MemarTommys' National Centre for Miscarriage Research, Queen Charlottes' & Chelsea Hospital, Imperial College, London, United Kingdom.
Paul DavisMologic LTD, Bedford Technology Park, Bedfordshire, United Kingdom.
Mark DavisMologic LTD, Bedford Technology Park, Bedfordshire, United Kingdom.
Julian Norman TaylorAcademic Department of Obstetrics and Gynaecology, Chelsea and Westminster Hospital, London, United Kingdom.
Paula AlmeidaAcademic Department of Obstetrics and Gynaecology, Chelsea and Westminster Hospital, London, United Kingdom.
Mark R JohnsonAcademic Department of Obstetrics and Gynaecology, Chelsea and Westminster Hospital, London, United Kingdom.
Richard HarveyDivision of Cancer, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Tom BourneTommys' National Centre for Miscarriage Research, Queen Charlottes' & Chelsea Hospital, Imperial College, London, United Kingdom.
Michael SecklDivision of Cancer, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Gary ClarkDepartment of Obstetrics, Gynaecology and Women's Health, University of Missouri, Columbia, Missouri, United States of America.
Stuart M HaslamDepartment of Life Sciences, Imperial College London, London, United Kingdom.
Anne DellDepartment of Life Sciences, Imperial College London, London, United Kingdom.
Imperial College London · GBChelsea and Westminster Hospital · GBQueen Charlotte's and Chelsea Hospital · GBMologic (United Kingdom) · GBUniversity of Missouri Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human chorionic gonadotropin (hCG) is a glycoprotein hormone that is essential for the maintenance of pregnancy. Glycosylation of hCG is known to be essential for its biological activity. "Hyperglycosylated" variants secreted during early pregnancy have been proposed to be involved in initial implantation of the embryo and as a potential diagnostic marker for gestational diseases. However, what constitutes "hyperglycosylation" is not yet fully understood. In this study, we perform comparative N-glycomic analysis of hCG expressed in the same individuals during early and late pregnancy to help provide new insights into hCG function, reveal new targets for diagnostics and clarify the identity of hyperglycosylated hCG. hCG was isolated in urine collected from women at 7 weeks and 20 weeks' gestation. hCG was also isolated in urine from women diagnosed with gestational trophoblastic disease (GTD). We used glycomics methodologies including matrix assisted laser desorption/ionisation-time of flight (MALDI-TOF) mass spectrometry (MS) and MS/MS methods to characterise the N-glycans associated with hCG purified from the individual samples. The structures identified on the early pregnancy (EP-hCG) and late pregnancy (LP-hCG) samples corresponded to mono-, bi-, tri-, and tetra-antennary N-glycans. A novel finding was the presence of substantial amounts of bisected type N-glycans in pregnancy hCG samples, which were present at much lower levels in GTD samples. A second novel observation was the presence of abundant LewisX antigens on the bisected N-glycans. GTD-hCG had fewer glycoforms which constituted a subset of those found in normal pregnancy. When compared to EP-hCG, GTD-hCG samples had decreased signals for tri- and tetra-antennary N-glycans. In terms of terminal epitopes, GTD-hCG had increased signals for sialylated structures, while LewisX antigens were of very minor abundance. hCG carries the same N-glycans throughout pregnancy but in different proportions. The N-glycan repertoire is more diverse than previously reported. Bisected and LewisX structures are potential targets for diagnostics. hCG isolated from pregnancy urine inhibits NK cell cytotoxicity in vitro at nanomolar levels and bisected type glycans have previously been implicated in the suppression of NK cell cytotoxicity, suggesting that hCG-related bisected type N-glycans may directly suppress NK cell cytotoxicity.

Indexed as

Protein Processing, Post-TranslationalCarbohydrate SequenceChorionic Gonadotropin, beta Subunit, HumanFemaleGestational AgeGestational Trophoblastic DiseaseGlycomicsGlycosylationHumansPolysaccharidesPregnancySpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTandem Mass SpectrometryChorionic Gonadotropin, beta Subunit, HumanPolysaccharides

Identifiers

PMID32045434
PMCPMC7012436
OpenAlexW3005962754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.